In hybridoma technology, the HAT resistance gene is often inserted into host cells. This gene provides resistance to the HAT (Hypoxanthine-Aminopterin-Thymidine) selection medium, allowing only the successfully transfected cells to survive and proliferate, facilitating the production of monoclonal antibodies.